Investigational Site Number : 1560031

Changchun 130021

1 studies enrolling now · 1 studies all time

What they study most

Dermatitis Atopic

Studies at this site

• A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in Participants Aged 12 Years and Older With Moderate-to-severe AD Who Have Had an Inadequate Response to Prior Biologic Therapy or an Oral JAK Inhibitor — Recruiting now